Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Bio-Medical Materials and Engineering Année : 2012

Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease

Résumé

Cardiovascular disease (CVD) is one of the main causes of mortality in the world representing around 30% of all deaths. It constitutes also an important factor in morbidity and incapacity. There are several related CVD risk factors such as hypertension, metabolic syndrome (MetS) and hypercoagulability. The exact mechanisms that underlie the relation between those factors and CVD are not sufficiently known yet; pathogenic explanations are lacking also for the mechanisms relating metabolic factors to insulin resistance (IR) and the association with the development of atherosclerosis and thrombosis. The possible links between hypertension, hemostasis alterations and MetS are examined in this report.
Fichier non déposé

Dates et versions

hal-03641775 , version 1 (14-04-2022)

Identifiants

Citer

Xianqing Mao, Karima Ait-Aissa, Jeremy Lagrange, Gina Youcef, Huguette Louis. Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease. Bio-Medical Materials and Engineering, 2012, 22 (1-3), pp.35-48. ⟨10.3233/BME-2012-0688⟩. ⟨hal-03641775⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More